AAO Updates HCQ Retinopathy Guidance - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

AAO Updates HCQ Retinopathy Guidance

Updated recommendations emphasize dosing limits and screening for toxicity risk.

  • By

  • Andrea Surnit

  • April 23, 2026

  • 3 min

Share

  • 1

    Hydroxychloroquine retinopathy risk is low with recommended dosing and appropriate screening, per the American Academy of Ophthalmology.

  • 2

    Updated guidelines emphasize early detection and risk factors for HCQ retinopathy, particularly in long-term female users.

  • 3

    Recommended screening modalities include optical coherence tomography and fundus autofluorescence, with additional confirmatory tests.

  • 4

    The risk of HCQ toxicity is under 1% at doses ≤5 mg/kg/day within 5 years, increasing with higher doses and longer use.

  • 5

    Annual screening is advised during therapy, but can be deferred for up to 5 years in patients without major risk factors.

Original Source(s)

AAO Updates HCQ Retinopathy Guidance

  • by Andrea Surnit

  • April 23, 2026

Related Content

Medical Oddities: Pig Semen, Meet Eye Drops

Evolution, sex, soil, and diets—this lineup covers a little bit of everything.

Subtle changes in the outer retinal and choroidal structures in individuals at elevated risk for advancing to age-related macular degeneration

2026 Retina World Congress Preview

Baruch D. Kuppermann, MD, PhD, highlights the global focus and broad retina agenda of the upcoming Retina World Congress meeting in Fort Lauderdale.